Medicine and Dentistry
Vasodilatation
100%
Nitric Oxide Synthase
66%
COVID-19
66%
Nitric Oxide
52%
Blood Pressure
45%
Salbutamol
40%
Pulse Wave Velocity
37%
Aortic Root
33%
Glyceryl Trinitrate
33%
Heart Ventricle Contractility
33%
Pulse Pressure
33%
Pulse Rate
33%
Nitric Acid Derivative
33%
N(g) Methylarginine
33%
Phosphodiesterase
33%
Placebo
31%
Hemodynamic
28%
Cyclic GMP
23%
Sildenafil
23%
Femoral Artery
20%
Endothelial Function
18%
Finger
16%
Heart Cycle
16%
Systolic Blood Pressure
16%
Hand Grip
16%
Endothelial Dysfunction
15%
Heart Output
13%
Vascular Resistance
13%
Cardiovascular Disease
11%
Aortic Pressure
11%
Sphygmomanometer
8%
Arginine
6%
Vascularity
6%
Mean Arterial Pressure
6%
Radioactive Tracer
6%
Volunteer
6%
Vascular Endothelium
6%
Artery Tone
6%
Human Study
5%
Arterial Tree
5%
Heart Ventricle Ejection
5%
Heart Ventricle Contraction
5%
Cardiac Catheterization
5%
Aortic Flow
5%
Intracoronary Drug Administration
5%
Intravenous Drug Administration
5%
Cardiovascular Physiology
5%
Systemic Vascular Resistance
5%
Ventricle of Heart
5%
Drug Megadose
5%
Neuroscience
Hypertension
72%
Vasodilation
66%
Nitric Oxide Synthase
66%
Nitric Oxide
66%
Salbutamol
61%
Cyclic Guanosine Monophosphate
44%
Sildenafil
44%
Cardiac Cycle
33%
Coronavirus
33%
Pulse Pressure
33%
Coronavirinae
33%
Phosphodiesterase
33%
Norepinephrine
26%
Dobutamine
26%
N(g) Methylarginine
20%
Behavior (Neuroscience)
11%
Body Mass Index
11%
Placebo
11%
Elastin
11%
Phosphodiesterase V
11%
Sympathomimetic Drug
11%
SARS Coronavirus
11%
Vasodilators
5%
In Vivo
5%
Cardiovascular Physiology
5%
Skeletal Muscle
5%
Pharmacology, Toxicology and Pharmaceutical Science
Salbutamol
61%
Sildenafil
57%
Cyclic GMP
44%
Neuronal Nitric Oxide Synthase
33%
Nitric Oxide
33%
Nitric Oxide Synthase
33%
Elastin
33%
Essential Hypertension
33%
Diseases
33%
Coronavirinae
33%
Phosphodiesterase
33%
Disease Predisposition
33%
Aortic Dissection
33%
Endothelial Dysfunction
22%
Phentolamine
13%
Cardiovascular Disease
11%
SARS Coronavirus
11%
Phosphodiesterase V Inhibitor
11%
Adrenergic Receptor Stimulating Agent
11%
Adrenergic Receptor Blocking Agent
6%
Placebo
6%
